CSBR
Champions Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.22
−1.14%Margins
Gross margin
48.0%
EBITDA margin
0.8%
EBIT margin
-1.9%
Net margin
-2.0%
FCF margin
-8.5%
-29.8%
Return on equity
-4.4%
Return on assets
-13.4%
Return on invested capital
2.14x
Asset turnover
-$4.5M
Cash from operations
$0.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026